Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06916260 · ClinicalTrials.gov registry record · NA

Light Therapy Intervention in Individuals With Parkinson's Disease

A NA study of Parkinson Disease, sponsored by University of Delaware.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT06916260 is a NA study of Parkinson Disease that is actively recruiting participants, run by University of Delaware. The registered enrollment target is 20 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06916260, a NA study of Parkinson Disease, is actively recruiting participants, sponsored by University of Delaware.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The study looks to investigate the effects that light therapy delivered to the frontal cortex could have on Parkinson's disease related symptoms ( both cognitive and motor). The therapy is a non invasive technique that deliverers low level wavelength light to the front part of the head for 12 minutes. for this study the therapy will be done 3 times a week for 6 weeks. To measure the potential effects on the therapy in Parkinson symptoms, we will do a set of cognitive and motor test before and after the intervention to measure any changes as well as control for any potential markers such as age, sex, disease level, medication and exercise.

Conditions Studied

Interventions

  • DEVICE Placebo
  • DEVICE Red Light (PDT)

Study Locations (1)

Delaware

  • University of Delaware STAR Tower - Newark

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2025-04-04
Est. Completion 2026-07-30
Phase NA

Sponsor

University of Delaware

106 total trials

What the Registry Record Tells You About NCT06916260

The ClinicalTrials.gov registry entry for NCT06916260 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The listed sponsor is University of Delaware, which has 106 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT06916260 reports 1 study location spanning 1 distinct geographic area - top geographies include Delaware.

Frequently Asked Questions

What is clinical trial NCT06916260 about?

NCT06916260 is a clinical study titled "Light Therapy Intervention in Individuals With Parkinson's Disease". The study looks to investigate the effects that light therapy delivered to the frontal cortex could have on Parkinson's disease related symptoms ( both cognitive and motor). The therapy is a non invasive technique that deliverers low level wavelength light to the front part of the head for 12 minute...

What is the current status of trial NCT06916260?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-04-04. Estimated completion is 2026-07-30.

What conditions does trial NCT06916260 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT06916260?

The interventions under investigation include: Placebo (DEVICE), Red Light (PDT) (DEVICE).

Who is sponsoring clinical trial NCT06916260?

This trial is sponsored by University of Delaware, which has 106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06916260 being conducted?

This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.